1,759 reports of this reaction
2.1% of all NAPROXEN SODIUM TABLET reports
#8 most reported adverse reaction
ARTHRALGIA is the #8 most commonly reported adverse reaction for NAPROXEN SODIUM TABLET, manufactured by Bayer HealthCare LLC.. There are 1,759 FDA adverse event reports linking NAPROXEN SODIUM TABLET to ARTHRALGIA. This represents approximately 2.1% of all 85,607 adverse event reports for this drug.
NAPROXEN SODIUM TABLET has an overall safety score of 78 out of 100. Patients taking NAPROXEN SODIUM TABLET who experience arthralgia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ARTHRALGIA is a less commonly reported adverse event for NAPROXEN SODIUM TABLET, but still significant enough to appear in the safety profile.
In addition to arthralgia, the following adverse reactions have been reported for NAPROXEN SODIUM TABLET:
The following drugs have also been linked to arthralgia in FDA adverse event reports:
ARTHRALGIA has been reported as an adverse event in 1,759 FDA reports for NAPROXEN SODIUM TABLET. This does not prove causation, but indicates an association observed in post-market surveillance data.
ARTHRALGIA accounts for approximately 2.1% of all adverse event reports for NAPROXEN SODIUM TABLET, making it a notable side effect.
If you experience arthralgia while taking NAPROXEN SODIUM TABLET, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.